Myriad Genetics, Inc.

NASDAQ:MYGN  
28.23
+1.37 (+5.10%)
Mergers / Acquisitions

Labcorp To Acquire Myriad Autoimmune's Vectra Testing Business From Myriad Genetics

Published: 05/03/2021 13:01 GMT
Myriad Genetics, Inc. (MYGN) - Labcorp to Acquire Myriad Autoimmune’s Vectra Testing Business From Myriad Genetics.
Labcorp - Specific Terms of Transaction Were Not Disclosed.